Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Tisotumab vedotin-tftv
Trade Name Tivdak
Synonyms HuMax-TF-ADC|TF-011-MMAE
Drug Descriptions

Tivdak (tisotumab vedotin-tftv) is an antibody-drug conjugate consists of anti-tissue factor (TF) antibody and the cytotoxic agent monomethyl auristatin E (MMAE), which induces killing of tumor cells overexpressing tissue factor (PMID: 24371232, PMID: 31796521). Tivdak (tisotumab vedotin-tftv) is FDA approved fro use in patients with with recurrent or metastatic cervical cancer (FDA.gov).

DrugClasses
CAS Registry Number 1418731-10-8
NCIT ID C113164

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Tisotumab vedotin-tftv Bevacizumab Tisotumab vedotin-tftv 0 1
Carboplatin + Tisotumab vedotin-tftv Carboplatin Tisotumab vedotin-tftv 0 1
Pembrolizumab + Tisotumab vedotin-tftv Pembrolizumab Tisotumab vedotin-tftv 0 1
Tisotumab vedotin-tftv Tisotumab vedotin-tftv 0 5


Additional content available in CKB BOOST